Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

NCT05471284 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2022-07-22

No results posted yet for this study

Summary

The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.

Conditions

  • Tobacco Smoking
  • Health Behavior

Interventions

BEHAVIORAL

Proximal

The first factor tested framing of the near, proximal threat of continued smoking.

BEHAVIORAL

Distal

The first factor tested framing of the long-term, distal threat of continued smoking.

BEHAVIORAL

Cost

Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.

BEHAVIORAL

Benefit

Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.

BEHAVIORAL

Loss

The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.

BEHAVIORAL

Gain

The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.

BEHAVIORAL

Control

Does not include any of the three message factors.

Sponsors & Collaborators

Principal Investigators

  • Jordan Neil, Ph.D. · TSET Health Promotion Research Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-11
Primary Completion
2019-04-01
Completion
2019-04-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471284 on ClinicalTrials.gov